Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revealing the impact of TOX3 on osteoarthritis: insights from bioinformatics. | Front Med (Lausanne) | 2023 | 38020130 | PubTator, text mining | PubMed |
| Diversity of short linear interaction motifs in SARS-CoV-2 nucleocapsid protein. | mBio | 2023 | 38018991 | PubTator, text mining | PubMed |
| Screening of key genes in the pathogenesis of muscle atrophy in CKD-PEW children based on RNA sequencing. | BMC Med Genomics | 2023 | 38017491 | PubTator, text mining | PubMed |
| Elucidating the clonal relationship of esophageal second primary tumors in patients with laryngeal squamous cell carcinoma. | Infect Agent Cancer | 2023 | 38017473 | PubTator, text mining | PubMed |
| N6-methyladenosine-modified circRIMS2 mediates synaptic and memory impairments by activating GluN2B ubiquitination in Alzheimer's disease. | Transl Neurodegener | 2023 | 38012808 | PubTator, text mining | PubMed |
| Identifying N6-Methyladenosine Sites in HepG2 Cell Lines Using Oxford Nanopore Technology. | Int J Mol Sci | 2023 | 38003667 | PubTator, text mining | PubMed |
| Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders. | Biomolecules | 2023 | 38002295 | PubTator, text mining | PubMed |
| Altered m6A RNA methylation governs denervation-induced muscle atrophy by regulating ubiquitin proteasome pathway. | J Transl Med | 2023 | 37996930 | PubTator, text mining | PubMed |
| Crucial role of hsa-mir-503, hsa-mir-1247, and their validation in prostate cancer. | Aging (Albany NY) | 2023 | 37980162 | PubTator, text mining | PubMed |
| Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy. | Acta Pharm Sin B | 2023 | 37969742 | PubTator, text mining | PubMed |
| An adaptive stress response that confers cellular resilience to decreased ubiquitination. | Nat Commun | 2023 | 37963875 | PubTator, text mining | PubMed |
| miRNAs: Targets to Investigate Herpesvirus Infection Associated with Neurological Disorders. | Int J Mol Sci | 2023 | 37958855 | PubTator, text mining | PubMed |
Exosomal Long Non-Coding Ribonucleic Acid Ribonuclease Component of Mitochondrial Ribonucleic Acid Processing Endoribonuclease Is Defined as a Potential Non-Invasive Diagnostic Biomarker for Bladder Cancer and Facilitates Tumorigenesis via the miR-206/G6PD Axis. | Cancers (Basel) | 2023 | 37958478 | PubTator, text mining | PubMed |
| A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma. | Aging (Albany NY) | 2023 | 37934582 | PubTator, text mining | PubMed |
| Genomic signatures of selection, local adaptation and production type characterisation of East Adriatic sheep breeds. | J Anim Sci Biotechnol | 2023 | 37932811 | PubTator, text mining | PubMed |
| 9-oxo-ODAs suppresses the proliferation of human cervical cancer cells through the inhibition of CDKs and HPV oncoproteins. | Sci Rep | 2023 | 37932321 | PubTator, text mining | PubMed |
| Analysis of Human microRNA Expression Profiling During Diquat-Induced Renal Proximal Tubular Epithelial Cell Injury. | J Inflamm Res | 2023 | 37927960 | PubTator, text mining | PubMed |
| Molecular mechanism of a novel root-end filling material containing zirconium oxide on the osteogenic/odontogenic differentiation of human osteosarcoma MG-63 cells. | Front Bioeng Biotechnol | 2023 | 37901837 | PubTator, text mining | PubMed |
| Creation of a Rat Takotsubo Syndrome Model and Utilization of Machine Learning Algorithms for Screening Diagnostic Biomarkers. | J Inflamm Res | 2023 | 37901384 | PubTator, text mining | PubMed |
| Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma. | Sci Rep | 2023 | 37898675 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=10